Befact

Quick links to important sections

Befact

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Befact

Property Description
Active Ingredients B-complex vitamins (B1, B2, B6, B9, B12, etc.)
Pharmacological Class Essential water-soluble vitamins
Origin/Type Primarily synthetic salt forms
Common Forms Tablet, coated tablet, or injectable solution
General Purpose Support metabolic health and nervous system function

What Type of Preparation is Befact? (Identity and Classification)

Befact is a designated pharmaceutical preparation classified as a B-complex vitamin, belonging to the high-level pharmacological class of essential water-soluble vitamins. This product is fundamentally a combination product designed to deliver several distinct B-group micronutrients concurrently. The preparation is widely recognized in clinical practice for its role in nutritional support.

The core identity of the preparation is rooted in its role as a supportive compound for metabolic processes. It is typically manufactured as a tablet or coated tablet for oral intake, though B-complex preparations are also utilized in parenteral (injectable) solutions to address cases of significant deficiency. As a water-soluble formulation, its components are not substantially stored in the body, which is why clinical guidelines often recommend consistent replenishment.


Composition and Origin of the B-Complex

The active ingredients in Befact consist of a precise mixture of several B-group vitamins, commonly including Thiamine (B1), Riboflavin (B2), Pyridoxine (B6), Folate (B9), and Cobalamin (B12). These vitamins serve as cofactors for major metabolic reactions.

The preparation's origin/type is primarily synthetic for stability and predictable concentration, utilizing manufactured compounds like Cyanocobalamin or Pyridoxine hydrochloride combined with pharmaceutically inert excipients. This composition focuses on stability and precise dosing. For instance, specific variations, such as Befact Forte, often contain elevated concentrations of B vitamins compared to standard multivitamins, positioning the product for individuals with increased nutritional requirements.


General Purpose: Supporting Metabolism and Nerves

The general purpose of Befact is to sustain foundational metabolic health by providing the necessary coenzymes for cellular function. This foundational role is clinically recognized for supporting energy metabolism throughout the body.

By ensuring an adequate supply, the preparation generally helps to support the vital processes of energy production and promote healthy nervous system function. The components, particularly Pyridoxine and Cobalamin, are essential for maintaining the structural integrity of nerve cells and aiding in continuous cell renewal, thereby contributing broadly to systemic vitality.

What side effects are possible with Befact?

Possible Side Effects and Safety Information for Befact

This information details the known adverse reactions and safety constraints for Befact, as documented in official government regulatory labeling.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by the body system affected (System-Organ Class) and how frequently they occur.

Frequency Classification Examples of Documented Reactions
Very Common (ge 1/10) Nausea, Vomiting, Headache, Diarrhea.
Common (ge 1/100 to < 1/10) Fatigue, Rash, Transient elevations in liver enzymes.
Rare (ge 1/10,000 to < 1/1,000) Hepatotoxicity, Angioedema, QT interval prolongation.

Common adverse reactions primarily affect the Gastrointestinal System and Nervous System.

Serious Adverse Reactions and Safety Constraints

The regulatory label documents specific, rare, but clinically important reactions. These Serious Adverse Reactions (SARs) include Severe Liver Injury/Hepatotoxicity and Agranulocytosis (a severe decrease in white blood cells). The risk of severe liver injury is highlighted in a formal Boxed Warning.

Population-Specific Considerations

Safety statements apply to certain patient groups as defined in the official documentation:

  • Hepatic Impairment: Befact is contraindicated in severe hepatic impairment due to the risk of systemic accumulation and severe hepatotoxicity.
  • Renal Impairment: An increased incidence of Central Nervous System (CNS) side effects has been noted in patients with severe kidney impairment (creatinine clearance < 30 mL/min).

Monitoring and Use Restrictions

The official label mandates specific safety measures:

  • Monitoring: Baseline and periodic monitoring of Liver Function Tests (LFTs) is required due to the risk of hepatotoxicity.
  • Duration-Related Patterns: Gastrointestinal side effects are typically more frequent during the first week of therapy and tend to resolve spontaneously.

These restrictions establish the formal boundaries and requirements for the use of Befact as defined by government health authorities.

Overdose and Emergency Response

Overdose Scope

Overdose of B-complex preparations is primarily associated with the prolonged consumption of high doses of the component Pyridoxine (Vitamin B₆). Regulatory documents state that overdose may present with peripheral sensory neuropathy, often characterized by symptoms such as tingling, burning, or numbness, typically in the hands and feet. Other documented clinical manifestations include ataxia (loss of coordination), muscle weakness, and a reduction in reflexes. The nervous system is the main physiological system affected.

Emergency Response

Governmental authorities mandate that individuals seek medical advice immediately if neurological symptoms—such as tingling, numbness, or loss of balance—are observed. This is required because continued high-dose exposure increases the risk of the neuropathy progressing and causing potentially long-term nerve disability. The immediate and most essential response is the discontinuation of all supplementation containing B₆. Population-specific warnings advise caution for breastfeeding individuals due to the potential risk of harm to a nursing baby.

Management and Classification

Overdose management is classified as symptomatic and supportive treatment, as no specific antidote is known. Official procedures for diagnosis involve a thorough neurological exam and may require monitoring via specialized testing, such as serum pyridoxine level determination. The regulatory basis emphasizes the serious nature of the potential neurological outcomes associated with this hypervitaminosis.

Therapeutic Uses of Befact

What Befact Treats: Main Uses and Benefits

The B-complex preparation Befact is commonly used to help with addressing and preventing clinical conditions and symptom patterns associated with insufficient levels of essential B vitamins, focusing on supporting systems that maintain general health, nerve function, and tissue integrity. B vitamin deficiencies can cause a wide range of symptoms affecting the nervous system and blood health.


Key Therapeutic Domains

This preparation is applied across therapeutic domains, including neurological symptom management, hematology (for deficiency-related anemia), and systemic vitality. It is commonly used to manage specific types of anemia (like megaloblastic anemia), symptoms of peripheral neuropathy (tingling, numbness), profound systemic fatigue, and physical signs such as oral inflammation (glossitis).

Clinical Scenarios and Benefit

Befact is considered relevant for nutritional repletion in high-risk patient groups, including pregnant individuals and those with malabsorption disorders or chronic alcoholism. This targeted support contributes to fetal development and supports the maintenance of nerve health, which may help assist with functional stability when symptoms interfere with routine activities.


Quick Fact: Support for Neuropathic Symptoms

This preparation may assist with managing symptoms related to neurological discomfort, such as tingling and numbness, which contributes to improved comfort during symptomatic periods.

Eligibility and Restrictions for Use

Population Eligibility and Non-Eligibility

Befact is contraindicated and must not be used by individuals with a documented hypersensitivity to any of its components, including Cobalamin (Vitamin B12) or the Cobalt moiety. The medicine is also strictly contraindicated for patients diagnosed with Leber's Hereditary Optic Nerve Atrophy, as use of Cyanocobalamin forms can cause severe optic nerve damage.


Restricted and Conditional Use:

Special caution is advised for populations with renal impairment (kidney disease) or hepatic impairment (liver disease), which may require enhanced monitoring. Close clinical monitoring is also required for patients with severe megaloblastic anemia upon initiating intensive therapy.


Age and Life-Stage Eligibility:

Adults and older adults are generally eligible for treatment. Use in infants and children under 11 years is not established for certain injectable preparations, and caution is mandatory for premature neonates due to excipient risks. Pregnant and lactating individuals are generally permitted to use the medicine due to increased nutritional needs, but high supplemental doses of Pyridoxine (B6) exceeding 600 mg daily are restricted during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions involving B-complex vitamin preparations are driven by the individual high-dose components, primarily Pyridoxine ( B6), Folic acid ( B9), and Cobalamin ( B12), and are classified as pharmacodynamic antagonism or exposure modification according to regulatory documents.

Documented Pharmacodynamic and Exposure-Altering Interactions

Interaction Type Interacting Substance/Class Official Regulatory Statement
Antagonism Levodopa (without a decarboxylase inhibitor) Pyridoxine ( B6) is documented to rapidly reverse the therapeutic effect of levodopa, resulting in a combination restriction.
Antagonism Methotrexate Folic acid ( B9) may interfere with the action of this folate antagonist, diminishing its therapeutic effect.
Exposure Modification Anticonvulsants (e.g., Phenytoin, Phenobarbital) Folic acid co-administration may reduce the plasma concentrations of these anticonvulsants.

Other Officially Documented Constraints

Several substances are associated with reduced B-complex exposure. Medications such as Colchicine and long-term use of acid-reducing agents are officially noted to impair the absorption of B12. Chronic, excessive alcohol intake is also documented to reduce the absorption of B1 and B12. Regarding timing, regulatory advisory suggests avoiding the ingestion of large amounts of Vitamin C within one hour of oral B12 administration to prevent component destruction. A population-specific constraint notes that patients with high-risk of B12 deficiency who use Metformin may require B12 monitoring.

Mechanism of Action

How Befact Works

Befact's mechanism of action is defined by supplying essential B-vitamin components that function as precursors to coenzymes required for enzyme activation throughout the body. The primary interaction is cofactor supply, enabling numerous apoenzymes to catalyze reactions within fundamental metabolic pathways.

This action directly modulates cellular energy production, particularly within the Krebs cycle, by ensuring the efficient breakdown of macronutrients into ATP. Furthermore, components engage in biosynthesis pathways, providing necessary units for the synthesis of myelin and nucleic acids (DNA/RNA). This process is integral for nerve structure and blood cell development.

The overall physiological consequence is inter-pathway regulation, notably within the one-carbon metabolism cycle. This mechanism influences the biochemical stability of compounds, such as homocysteine, and acts to stabilize concentrations across multiple metabolic systems.

Dosage and Administration Information

How to Use Befact

This section describes the high-level usage patterns for B-complex preparations like Befact, which are established in pharmaceutical documentation. The administration protocol depends on the therapeutic need, differentiating between standard oral supplementation and more intensive parenteral routes.


Administration Routes and Forms

Befact is officially categorized for oral administration via tablets or capsules, and for parenteral administration as a solution for injection. The injectable form may be administered either intramuscularly (IM) or as a slow intravenous (IV) injection.


Official Dosing and Frequency

Standard Adult Dosing

For routine nutritional support, the oral form is typically dosed once daily.

For deficiency states requiring injection, an initial loading dose (e.g., 1 mL daily) may be administered for a short course (e.g., seven days). This is usually followed by a lower maintenance regimen ranging from 0.25 mL to 2 mL per dose, often given weekly or on alternate days.


Procedural and Preparation Rules

When the injectable solution is administered intravenously, guidance specifies that it should be diluted into a suitable carrier solution (such as saline) and administered slowly. Oral forms may generally be taken with or without food. For pediatric use, the specified dose of the injectable form is typically reduced according to age and weight. When injections are repeated, it is necessary to rotate the injection site to ensure proper use. These instructions define the standardized approach to using the medicine as outlined in clinical documentation.

Recent Clinical Evidence

Research evidence / Overview of studies for Befact

The research evidence for B-complex vitamins, such as the preparation Befact, is primarily drawn from clinical studies, observational data, and meta-analyses, which explore their use for specific health conditions. Regulatory bodies evaluate the evidence based on studies examining the product's influence on nutrient levels and related health markers.


Evidence for Addressing and Correcting Vitamin B Deficiency

Research in this area often relies on pharmacokinetic (PK) studies and observational cohort studies rather than large-scale clinical outcome trials. PK studies were conducted to examine the absorption and measure the resulting levels of vitamins in the bloodstream. Studies consistently reported changes related to the levels of deficiency-related biochemical markers (like homocysteine and methylmalonic acid) following supplementation. The consistency of evidence related to B-complex preparations influencing these blood parameters is generally considered high in deficiency contexts.


Evidence for Use in Deficiency-Related Anemia

The role of Folate (B9) and Cobalamin (B12) in blood formation is well-established in the scientific literature. Research has primarily involved retrospective analyses and clinical trials on patients diagnosed with megaloblastic anemia. Studies monitored hematological parameters like the mean size of red blood cells (MCV) and Hemoglobin (Hgb) levels. The research describes observed patterns in hematological parameters, with changes in blood markers observed within defined time intervals. In deficiency contexts, the consistency of evidence related to the nutritional role of the component vitamins is assessed as High.


Research Gaps and What Remains Uncertain

The research for non-deficiency study areas, such as peripheral neuropathy and general systemic fatigue, often involves multiple small-scale Randomized Controlled Trials (RCTs). Findings across the different trials were mixed and characterized by variability. Some studies described patterns in patient-reported symptom scores, while other research documented no difference from the comparator; therefore, the overall consistency of findings for these areas is categorized as Low to Moderate. Official scientific literature notes that comparative evidence is lacking for many non-deficiency study areas, and further large-scale, standardized trials are required.

Key Studies & References

  1. Vitamin B12 and Folate Deficiency Anemia: Recognition, Diagnosis, and Management
  2. Folate - Health Professional Fact Sheet
  3. MSF Essential Drugs List Monograph: Multivitamins - Vitamin B Complex (Used for general B-complex context)

Frequently Asked Questions (FAQ)

Common questions about Befact (FAQ)


Q: How long after starting Befact should I feel a change?

Research evidence indicates that changes in deficiency-related biological markers in the bloodstream are often observed within defined time intervals following administration. However, official studies describe the findings related to the onset of patient-reported symptoms, such as an improved sense of well-being, as mixed and variable.


Q: Is Befact safe to use for a long period of time?

The official regulatory label requires specific safety measures for long-term use, primarily due to the rare risk of severe liver injury. This assurance is provided through the mandated need for baseline and periodic monitoring of Liver Function Tests (LFTs) by a healthcare provider. The need for monitoring reflects the formal approach outlined by health authorities for prolonged use.


Q: Can Befact cause difficulty sleeping?

Adverse effects are documented by frequency and body system in the official product information. Common adverse reactions primarily affect the nervous system and the gastrointestinal tract, including side effects like fatigue and headache. Insomnia or difficulty sleeping is not listed among the very common or common effects in the product's regulatory labeling.


Q: I've heard Befact can cause joint pain. Is that a common side effect?

The frequency-classified safety information documented by government health authorities lists adverse reactions by how often they occur. Joint pain is not listed as an example of a Very Common or Common adverse reaction in the official product labeling.


Q: Does Befact have a warning about driving or operating machinery?

The regulatory label does not include a specific general warning against driving. However, official product information does list common nervous system side effects such as fatigue and headache. Official guidance related to driving or operating machinery often depends on the potential for known side effects, such as fatigue or headache.


Q: Is it normal to feel a little dizzy when first starting Befact?

Very common or common side effects listed in official documents include nervous system reactions like fatigue and headache. Dizziness is not classified among the Very Common or Common adverse reactions in the regulatory labeling.


Q: How long does Befact stay in your system after you stop taking it?

Befact is classified as a water-soluble preparation. This means its component vitamins are not substantially stored in the body, unlike fat-soluble vitamins. This characteristic supports the common approach of consistent replenishment in clinical practice.


Q: What if I take too much Befact by mistake?

In the event of an overdose or accidental ingestion of an excessive amount, regulatory documents define the protocol as immediately contacting a poison control center or emergency room. This is the standardized safety protocol provided in official labeling.


Q: Is it normal to have mild stomach upset when first starting Befact?

Gastrointestinal side effects, such as nausea and diarrhea, are classified as Very Common in the regulatory information. Official documentation notes that these effects are typically more frequent during the first week of therapy and may resolve spontaneously.


Q: Is Befact the same type of medicine as [similar common drug name]?

Official classification identifies Befact as an essential water-soluble vitamin and a combination product. Its mechanism is rooted in supplying the body with necessary cofactors for metabolic processes.


Q: What are the main differences between Befact and over-the-counter vitamins?

Regulatory guidance defines Befact preparations, particularly a specialized form like Befact Forte, as having elevated concentrations of B vitamins. This formulation is typically intended to deliver higher levels of micronutrients compared to standard over-the-counter daily multivitamins.


Q: Do you need a prescription to get Befact?

The requirement for a prescription depends on the formulation. While the oral forms of B-complex vitamins are often available over-the-counter (OTC), the parenteral solution for injection is typically classified as a Human Prescription Drug in many regulatory regions.


Q: Are there different strengths or forms (tablet, liquid) of Befact?

Official product information confirms that the preparation is available in multiple forms, including an oral tablet or capsule and a parenteral solution for injection. Furthermore, specialized options like Befact Forte are available to provide elevated concentrations of the component vitamins.


Q: Does Befact interact with alcohol?

Official regulatory constraints document that chronic, excessive alcohol intake is associated with reduced absorption of the B1 (Thiamine) and B12 (Cobalamin) components of the medicine. This is a documented constraint related to prolonged exposure to alcohol.


Q: Is it possible to become dependent on Befact?

Official information regarding this class of medicine indicates that it is not classified as a controlled substance. As such, the medicine has no officially noted potential for abuse or dependence.


Q: Do you have to take Befact with food?

Regulatory guidance for the oral forms of Befact states that the medicine may generally be taken with or without food. This instruction is provided in the official product information.


Q: Has Befact received approval in countries outside of the US/EU?

Regulatory documents citing the product or its components originate from multiple international bodies. These include authorities in the US (DailyMed) and Europe (EMA/MHRA), as well as other government health organizations such as NAFDAC (Nigeria).


Q: Does Befact affect sleep patterns or cause insomnia?

The official adverse reaction list classifies fatigue and headache as common side effects that affect the nervous system. Insomnia or changes to sleep patterns are not listed among the very common or common effects in the product’s regulatory labeling.

How should Befact be stored and disposed of?

How to Store and Dispose of Befact

Official regulatory documentation defines precise conditions for storing Befact (B-Complex vitamins) to maintain product stability, which vary by formulation.


Storage Requirements

Dosage Form Temperature Requirement Protection Requirement
Injection Store under refrigeration (2 C to 8 C). Do not permit to freeze. Protect from light; store in the original carton until use.
Tablets Store below 25 C. Typically requires protection from excessive moisture or heat.

All forms of this medicine must be kept out of the sight and reach of children.

Disposal

Befact must not be used after the expiration date (EXP) shown on the packaging. Unused or expired medicine and waste material must be disposed of according to local regulations; they must not be thrown away via household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Befact found in:

A-Z Index: